Themis Medicare Limited (NSE:THEMISMED)
101.73
-0.08 (-0.08%)
Jun 19, 2026, 3:30 PM IST
Themis Medicare Revenue
In the fiscal year ending March 31, 2026, Themis Medicare had annual revenue of 3.42B INR, down -15.60%. Themis Medicare had revenue of 765.31M in the quarter ending March 31, 2026, with 6.73% growth.
Revenue
3.42B
Revenue Growth
-15.60%
P/S Ratio
2.74
Revenue / Employee
2.01M
Employees
1,702
Market Cap
9.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.42B | -632.76M | -15.60% |
| Mar 31, 2025 | 4.06B | 237.51M | 6.22% |
| Mar 31, 2024 | 3.82B | 274.38M | 7.74% |
| Mar 31, 2023 | 3.54B | -402.91M | -10.21% |
| Mar 31, 2022 | 3.95B | 1.64B | 71.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Solara Active Pharma Sciences | 13.69B |
| Windlas Biotech | 9.04B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 6.41B |
| Sigachi Industries | 4.86B |
| Beta Drugs | 3.85B |
| Jagsonpal Pharmaceuticals | 2.87B |
Themis Medicare News
- 1 year ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn